Loading... Please wait...
Sort by:

 

FirstView NPS+

An expanded view of brand loyalty among doctors

Actionable metrics to help you make better brand decisions

 

Net Promoter Score (NPS) is an easy way to measure brand health, but it doesn’t tell you how to improve it. NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty

 

Each NPS+ report examines doctors’ relationships with the brands used to treat a major disease area—measuring brand loyalty and showing you how it affects your market share. NPS+ also examines “brand DNA”, revealing in doctors’ own words what brands mean to them.

 

Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.

  • NPS+ Haemophilia B (EU5) 2018
    Learn More NPS+ Haemophilia B (EU5) 2018
    Why are some EU5 Haemophilia B brands standing out more than others?  There are various options available to EU5 haematologists treating haemophilia B. Clearly some of these options are achieving greater levels of...
  • NPS+ Rheumatoid Arthritis (EU5) 2018
    Learn More NPS+ Rheumatoid Arthritis (EU5) 2018
    Understand which rheumatoid arthritis brands are winning the hearts and minds of rheumatologists in Europe There are various options available to EU5 rheumatologists to treat rheumatoid arthritis (RA). Clearly some of...
  • NPS+ Rheumatoid Arthritis (US) 2018
    Learn More NPS+ Rheumatoid Arthritis (US) 2018
    Understand which rheumatoid arthritis brands are winning the hearts and minds of rheumatologists in the US There are various options available to US rheumatologists to treat rheumatoid arthritis (RA). Clearly some of...
  • NPS+ Non-Small Cell Lung Carcinoma (EU5) 2018
    Learn More NPS+ Non-Small Cell Lung Carcinoma (EU5) 2018
    Understand which NSCLC brands are winning the hearts and minds of medical oncologists in Europe There are various options available to European medical oncologists to treat non-small-cell lung carcinoma (NSCLC). Clearly...
  • NPS+ Non-Small Cell Lung Carcinoma (US) 2018
    Learn More NPS+ Non-Small Cell Lung Carcinoma (US) 2018
    Understand which NSCLC brands are winning the hearts and minds of medical oncologists in the US There are various options available to US medical oncologists to treat non-small-cell lung carcinoma (NSCLC). Clearly some...
  • NPS+ Ulcerative Colitis (EU5) 2018
    Learn More NPS+ Ulcerative Colitis (EU5) 2018
    Why are some European ulcerative colitis brands standing out more than others? There are various options available to European gastroenterologists treating ulcerative colitis. Clearly some of these options are achieving...
  • NPS+ Ulcerative Colitis (US) 2018
    Learn More NPS+ Ulcerative Colitis (US) 2018
    Why are some US ulcerative colitis brands standing out more than others? There are various options available to US gastroenterologists treating ulcerative colitis. Clearly some of these options are achieving greater...
  • NPS+ Haemophilia A (EU5) 2018
    Learn More NPS+ Haemophilia A (EU5) 2018
    Why are European haemophilia A brands failing to stand out with physicians? There are various options available to European haematologists treating haemophilia A. And most brands, it would seem, are having a torrid time...
  • NPS+ Haemophilia A (US) 2018
    Learn More NPS+ Haemophilia A (US) 2018
    Why are US haemophilia A brands failing to stand out with physicians? There are various options available to US haematologists treating haemophilia A. And most brands, it would seem, are having a torrid time in carving...
  • NPS+ Asthma/COPD (EU5) 2018
    Learn More NPS+ Asthma/COPD (EU5) 2018
    Why are some European asthma/COPD brands standing out more than others?  There are various options available to European pulmonologists and primary care physicians treating asthma and COPD. Clearly some of these...
  • NPS+ Asthma/COPD (US) 2018
    Learn More NPS+ Asthma/COPD (US) 2018
    Why are some US asthma/COPD brands standing out more than others? There are various options available to US pulmonologists and primary care physicians treating asthma and COPD. Clearly some of these options are...
  • NPS+ Type 2 Diabetes Mellitus [Orals] (EU5) 2018
    Learn More NPS+ Type 2 Diabetes Mellitus [Orals] (EU5) 2018
    There are various oral therapeutic options available to EU5 diabetologists treating type 2 diabetes mellitus. Clearly some of these options are achieving greater levels of loyalty and satisfaction than others – but...
  • NPS+ Type 2 Diabetes Mellitus [Orals] (US) 2018
    Learn More NPS+ Type 2 Diabetes Mellitus [Orals] (US) 2018
    There are various oral therapeutic options available to US diabetologists treating type 2 diabetes mellitus. Clearly some of these options are achieving greater levels of loyalty and satisfaction than others – but...
  • NPS+ Psoriasis (EU5) 2018
    Learn More NPS+ Psoriasis (EU5) 2018
    Why are some EU5 psoriasis brands standing out more than others? There are various options available to EU5 dermatologists treating psoriasis. Clearly some of these options are achieving greater levels of loyalty and...
  • NPS+ Psoriasis (US) 2018
    Learn More NPS+ Psoriasis (US) 2018
    Why are some US psoriasis brands standing out more than others? There are various options available to US dermatologists treating psoriasis. Clearly some of these options are achieving greater levels of loyalty and...
  • NPS+ HIV (EU5) 2018
    Learn More NPS+ HIV (EU5) 2018
    Why are some EU5 HIV brands standing out more than others? There are various options available to EU5 infectious disease specialists treating HIV. Clearly some of these options are achieving greater levels of loyalty...

customer.service@firstwordpharma.com

All Contents Copyright © 2018 Doctor's Guide Publishing Limited All Rights Reserved